Volume 18, Number 5—May 2012
Letter
Possible Nosocomial Transmission of Pneumocystis jirovecii
Table
Patient no.† | No. days between pulmonary and air sampling | ITS genotype (no. sequenced clones)‡ |
DHPS genotype§ |
|||
---|---|---|---|---|---|---|
Pulmonary sample | Air sample | Pulmonary sample | Air sample | |||
1 | 6 | Gg, Fg (3)¶ | ND | Wild | ND | |
2 | 1 | Ih (3) | Eg (3) | Wild | ND | |
4 | 0 | Gg (3) | Gg (3) | Wild | Wild | |
5 | 0 | Eg (3) | Ec, Eg (3)¶ | Wild | Wild | |
6 | 0 | Eg (3) | Eg (3) | Mutant 171# | Mutant 171 | |
7 | 1 | Eg (3) | ND | Wild | Wild | |
8 | 0 | Eg (2) | Eg (1) | Wild | ND | |
10 | 0 | Eg (3) | ND | Mutant 171 | ND | |
11 | 0 | Be, Ec (3¶) | Ec (3) | Mutant 165** | Mutant 165 | |
13 | 2 | Eg (3) | ND | Wild | ND | |
15 | 0 | Eg, Fg (3)¶ | ND | Wild + mutant 171 | ND | |
16 | 0 | Eg (3) | ND | Wild | Wild | |
17 | 1 | Ie, Ih (2) | ND | Wild | ND | |
18 | 1 | Bl (3) | Bl (3) | Wild + mutant 165 | ND | |
19 | 0 | Eg, Bl (3¶) | ND | Wild + mutant 165 | ND |
*ITS, internal transcribed spacers; DHPS, dihydropteroate synthase;
†Patients are numbered as described in (6). Pulmonary samples were bronchoalveloar lavage specimens for patients 2, 4, 6, 7, 8, 10, 11, 18, and 19 and induced sputum specimens for patients 1, 5, 13, 15, 16, and 17.
‡P. jirovecii ITS genotype identification using sequence analysis with a prior cloning step and applying the score by Lee et al. (2).
§P. jirovecii DHPS genotype identification using a PCR restriction fragment length polymorphism assay (8).
¶Major ITS genotype, as identified in 2 of 3 clones.
#Mutant genotype with the mutation at position 171.
**Mutant genotype with the mutation at position 165.
References
- Beard CB, Roux P, Nevez G, Hauser PM, Kovacs JA, Unnasch TR, Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg Infect Dis. 2004;10:1729–35.PubMedGoogle Scholar
- Lee CH, Helweg-Larsen J, Tang X, Jin S, Li B, Bartlett MS, Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol. 1998;36:734–41.PubMedGoogle Scholar
- Iliades P, Meshnick SR, Macreadie IG. Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs. Antimicrob Agents Chemother. 2005;49:741–8. DOIPubMedGoogle Scholar
- Nevez G, Chabe M, Rabodonirina M, Virmaux M, Dei-Cas E, Hauser PM, Nosocomial Pneumocystis jirovecii infections. Parasite. 2008;15:359–65.PubMedGoogle Scholar
- de Boer MG, de Fijter JW, Kroon FP. Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review. Med Mycol. 2011;49:673–80.PubMedGoogle Scholar
- Choukri F, Menotti J, Sarfati C, Lucet JC, Nevez G, Garin YJ, Quantification and spread of Pneumocystis jirovecii in the surrounding air of patients with Pneumocystis pneumonia. Clin Infect Dis. 2010;51:259–65. DOIPubMedGoogle Scholar
- Totet A, Pautard JC, Raccurt C, Roux P, Nevez G. Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia. J Clin Microbiol. 2003;41:1173–80. DOIPubMedGoogle Scholar
- Totet A, Latouche S, Lacube P, Pautard JC, Jounieaux V, Raccurt C, Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France. Emerg Infect Dis. 2004;10:667–73.PubMedGoogle Scholar
Page created: April 06, 2012
Page updated: April 06, 2012
Page reviewed: April 06, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.